Bafna Pharmaceuticals Ltd

BSE: 532989

total announcements

532989.BO · 15 min delayed

BSECompany UpdateMgmt Change22 Jun 2026

Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

Bafna Pharmaceuticals Ltd announced the retirement of Mr. Navin Kumar, an Independent Director, upon completing his first term effective June 22, 2026. Consequently, he will also cease to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee. The company has reconstituted these committees to ensure continued compliance with regulatory requirements, affirming that the board composition remains compliant.

Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

Bafna Pharmaceuticals Ltd announced the routine retirement of Mr. Navin Kumar, an Independent Director, upon the completion of his first term, effective June 22, 2026. As a result, he will also cease to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee. The company has subsequently reconstituted these committees, stating that the composition of the Board and its committees remains compliant with applicable regulations.